Bentamapimod

DB16851InvestigationalSmall molecule

Bentamapimod: Overview.

Mechanism: Pharmacologically active on c-Jun N-terminal kinases
Curator reviewed
Formula / weight: C₂₅H₂₃N₅O₂S · 457.55 g/mol (avg)
Code names: AS-602801 · PGL-5001

Resolves to

Compound

Structure

InChIKeyXCPPIJCBCWUBNT-UHFFFAOYSA-NSMILESN#CC(C1=NC2=C(S1)C=CC=C2)C1=CC=NC(OCC2=CC=C(CN3CCOCC3)C=C2)=N1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Bentamapimod, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.